[EFFECT OF VITAMIN K 3 (VIKASOL) ON THE ACTIVITY OF ANTICHOLINESTERASE SUBSTANCES].
D000818:Animals; D000933:Antifibrinolytic Agents; D001001:Anura; D001285:Atropine; D002800:Cholinesterase Inhibitors; D051379:Mice; D009285:Naphthoquinones; D009388:Neostigmine; D010600:Pharmacology; D010710:Phosphates; D012106:Research; D014116:Toxicology; D014812:Vitamin K; D024483:Vitamin K 3
D000933:Antifibrinolytic Agents; D002800:Cholinesterase Inhibitors; D009285:Naphthoquinones; D010710:Phosphates; D014812:Vitamin K; D009388:Neostigmine; D024483:Vitamin K 3; D001285:Atropine
ATROPINE; CHOLINESTERASE INHIBITORS; EXPERIMENTAL LAB STUDY; FROGS; MICE; NEOSTIGMINE; PHARMACOLOGY; PHOSPHATES; TOXICOLOGIC REPORT; VITAMIN K
VLIIANIE VITAMINA K3 (VIKASOLA) NA DE ISTVIE ANTIKHOLIN'ESTERAZNYKH VESHCHESTV.